Recalls & Warnings July 06, 2022 FDA Warns Kratom Companies for Arthritis, Pain Relief Claims & More On January 30, 2022, the FDA issued warning letters to four sellers of kratom products because they were promoted to treat pain relief, opioid withdrawal, blood sugar control, anxiety, and to treat rheumatoid arthritis
Common mistakes and how to avoid them Most AOD-9604 protocols fail not due to the peptide itself but due to avoidable errors in preparation, administration, or supporting behaviors
It is essential to distinguish medically indicated B12 replacement therapy from commercially marketed wellness injections, as they serve fundamentally different purposes and are subject to different regulatory oversight
This large muscle is easily identified on the upper, outer thigh making it a safe injection site for self-administration
Here is what the current research can actually support